Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination - United States, September and December 2020
This report describes increases in intent and decreases in nonintent to receive COVID-19 vaccination among adults and across all vaccine priority groups from September to December 2020.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416678
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021
The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Decreases in Young Children Who Received Blood Lead Level Testing During COVID-19-34 Jurisdictions, January-May 2020
This report describes a decrease in blood lead level testing among children aged <6 years during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416390
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020
This report describes racial and ethnic disparities in stress and worry, mental health, and substance use during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416391
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021
On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421658
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021
This report describes demographic data of persons who received at least 1 dose of vaccine during the first month of the U.S. COVID-19 vaccination program.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416286
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019 and January 1-September 30, 2020
This report describes how California's stay-at-home order during the COVID-19 pandemic has affected cervical cancer screening rates.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=416062
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539
Etiketler:

EklenmeTarihi: 30 Ekim 2021, Cumartesi, 00:09
Bilgi: Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021
This report describes cases of anaphylaxis after administration of first doses of the Moderna COVID-19 vaccine during December 21, 2020-January 10, 2021.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=415958
Etiketler: